Filter
3247
Filtered Results: 3247
Text search:
WHO
drug
use
indicators
Featured
Recommendations
272
New Publications
1014
Language
Document type
No document type
2125
Studies & Reports
483
Guidelines
322
Manuals
121
Strategic & Response Plan
121
Training Material
26
Fact sheets
22
Situation Updates
17
Infographics
8
Brochures
1
Online Courses
1
Countries / Regions
India
199
Kenya
117
Global
100
Ethiopia
94
Uganda
90
Nepal
81
Nigeria
75
Tanzania
75
Malawi
75
Western and Central Europe
69
South Africa
65
Zambia
64
Sierra Leone
62
Liberia
62
Ghana
57
Bangladesh
54
Myanmar / Burma
52
Latin America and the Carribbean
51
Rwanda
45
Africa
44
Namibia
41
Ukraine
33
Eastern Europe
33
Zimbabwe
32
Philippines
31
Cambodia
30
Lesotho
29
South–East Asia Region
28
Asia
25
Indonesia
21
Botswana
20
Congo, Democratic Republic of
17
Senegal
16
Burkina Faso
15
Eswatini/ Swaziland
15
Mozambique
14
Cameroon
11
East and Southern Africa
11
Russia
11
Haiti
10
Pakistan
10
Syria
10
Eastern Europe and Central Asia
10
Colombia
9
West and Central Africa
9
Albania
9
Georgia
9
Brazil
8
Middle East and North Africa
8
Venezuela
8
South Sudan
6
Thailand
6
Moldova
6
Guinea
5
USA
5
Germany
5
Lebanon
5
Sudan
5
Peru
5
Laos
5
China
4
Benin
4
Argentina
4
North Macedonia
4
Western Pacific Region
4
Armenia
4
Tajikistan
4
Vietnam
4
Iraq
3
Jordan
3
Afghanistan
3
Papua New Guinea
3
El Salvador
3
Bolivia
3
Mexico
3
Sri Lanka
3
Chile
3
Bhutan
3
Timor Leste/ East Timor
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Turkey
2
Central African Republic
2
Honduras
2
Paraguay
2
Mongolia
2
Estonia
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
North America
2
Turkmenistan
2
France
2
United Kingdom
2
Portugal
2
Spain
2
Niger
1
Somalia
1
Gambia
1
Ireland
1
Singapore
1
Serbia
1
Hungary
1
Greece
1
Libya
1
Guatemala
1
Madagascar
1
Nicaragua
1
Fiji
1
Poland
1
Palestine
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Gabon
1
Uruguay
1
Jamaica
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1494
Clinical Guidelines
254
Public Health
178
Women & Child Health
109
Key Resources
78
Pharmacy & Technologies
40
Capacity Building
35
Toolboxes
HIV
384
TB
301
Mental Health
226
AMR
182
NTDs
90
COVID-19
83
Pharmacy
77
Caregiver
64
NCDs
62
Rapid Response
57
Planetary Health
40
Disability
32
Conflict
31
Global Health Education
31
Refugee
27
Ebola
25
Polio
14
Health Financing Toolbox
14
Natural Hazards
12
Cholera
10
Specific Hazards
9
Zika
6
Social Ethics
4
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tub...
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug ... as a crime that cannot be tolerated and should be punished; the other views addiction as a chronic relapsing health or behavioral condition requiring ongoing treatment and support. Neither of these views is all encompassing—it should be recognized that there are patterns of drug use that do not result in significant harm or health problems and therefore require no intervention. The public health approach presented here takes the view that our focus should be on the harm caused by drug use and the harm caused by our policy responses to it. We have focused specifically on illicit drugs, not because they are by themselves more harmful (in fact, tobacco causes more morbidity and mortality than any illicit drug), but because it has become increasingly clear that our current policies to manage illicit drugs are failing."
BMJ Global Health Vol.4 (2019 no.4
The Drug Resistance Index (DRI) is proposed as measure of antibiotic effectiveness in a given country, by combining, in a single metric the use of various antibio...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health prob...
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second Wo...
The Core Set of Indicators and respective Indicator Data Sheets aim to pave the way towards a common understanding, greater consistency and comparability across countries and alignment of results ch...
This year marked the beginning of the WHO biennium 2016-2017 action plan; this annual report highlights WHO’s key achievements in 2016
It also documents the extraordinary efforts by a broad coal...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical ... at the global level. It also reviews the latest trends in the global supply of opiates and synthetic opioids and the availability of pharmaceutical opioids for medical consumption. Issues specific to regional patterns and trends in opioid markets are also analysed, including the opioid crisis in North America and in Africa and the Middle East. The chapter also includes a discussion of the potential impact, in the region and worldwide, of changes in opium poppy cultivation and opium production in Afghanistan. reireg
This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders.
The manual will be useful to any researcher or clinician wishing to ... WHODAS 2.0 in their practice. It includes the seven versions of WHODAS 2.0, which differ in length and intended mode of administration. It also provides general population norms; these allow WHODAS 2.0 values for certain subpopulations to be compared with those for the general population.
Final Evaluation
The project objectives were to promote the conservation, sustainable use and cultivation of endangered medicinal plants in Zimbabwe, by demonstrating effective models at the local level, and developing a legal framework for the...
The project objectives were to promote the conservation, sustainable use and cultivation of endangered medicinal plants in Zimbabwe, by demonstrating effective models at the local level, and developing a legal framework for the...
Self-care interventions are among the most promising and exciting new approaches to improve health and well-being, both from a health systems perspective and for people who use these interventions. ...
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are al...
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscitator, is indispensable medical device to save newborns from asphyxia at birth. For the efficient ... of neonatal resuscitation, training of healthcare professionals using neonatal resuscitation manikins is the most effective approach. Critical lifesaving trainings calls for the need of neonatal resuscitation manikins with the right features.
The purpose of the WHO Neonatal resuscitation manikin: technical specifications is to provide a minimum standard baseline to meet the increasing demand to procure good quality, affordable, accessible, and appropriate neonatal resuscitation manikins. Towards the development of this baseline, this document includes compilation of available scientific evidence from technical literature, international publications, expert reviews, and an industry survey which was conducted by WHO medical devices team.
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. Wi...
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (WHO) into an organization that is proactive, results-driven, accountable and which meets stakeholder expectations, towards tra...
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous ... publications: the Guidelines for the treatment of malaria, third edition and the Guidelines for malaria vector control. Recommendations on malaria will continue to be reviewed and, where appropriate, updated based on the latest available evidence. Any updated recommendations will always display the date of the most recent revision in the MAGICapp platform. With each update, a new PDF version of the consolidated guidelines will also be available for download on the WHO website.
This version of the Guidelines includes updates to the case management of malaria, specifically the addition of new molecules for the treatment of uncomplicated malaria and optimization of the dosage regimen for anti-relapse treatment, along with updates on the use of antimalarial medicines in special risk populations including pregnant women.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (Table 1) are based on guidelines published in 2013 i...
